drugset / Trial / NCT02591771

Study of Multistep Pharmacological and Invasive Management for Cardiogenic Shock

NCT02591771

Phase 2 Completed 24 enrolled Niguarda Hospital Ospedale San Raffaele · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate efficacy and safety of i.v. adrenaline infusion as an early and fast haemodynamic stabilizer, associated with a tight tissue perfusion monitoring, in the context of a stepwise progression in the treatment of cardiogenic shock, including ventricular mechanical support.

Timeline

Start
2015-10
Primary completion
2017-07-25
Completion
2017-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinephrine Other / unclassified 0.08 ug/kg Intravenous

Indications